Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yongfeng Ding

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
American Journal of Cancer Research|April 1, 2021
FSTL1 promotes growth and metastasis in gastric cancer by activating AKT related pathway and predicts poor survivalMengjie Wu, Yongfeng Ding, Nan Wu, et al.
Journal of Cancer|April 4, 2022
EXOSC5 promotes proliferation of gastric cancer through regulating AKT/STAT3 signaling pathwaysXiangliu Chen, Yingying Huang, Jin Liu, et al.
Heliyon|August 22, 2024
The combination of exon sequencing and metabolomics to establish a molecular typing system for gastric cancerShanshan Yu, Ming Chen, Xiaohua Zhu, et al.
Biomed Research International|July 18, 2019
Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric CancerJie Zhou, Wenyi Zhao, Jingcheng Wu, et al.
Frontiers in Immunology|February 26, 2021
Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to TherapyWeiqin Jiang, Yinjun He, Wenguang He, et al.
Journal of Translational Medicine|October 2, 2019
90-gene signature assay for tissue origin diagnosis of brain metastasesYulong Zheng, Yongfeng Ding, Qifeng Wang, et al.
Cancer Medicine|October 3, 2023
The Memorial Sloan Kettering Prognostic Score: Correlation with survival in patients with advanced gastric cancerMingyu Wan, Yongfeng Ding, Xiaolu Ma, et al.
Frontiers in Immunology|July 15, 2022
Development of a Humanized VHH Based Recombinant Antibody Targeting Claudin 18.2 Positive CancersWeixiang Zhong, Yimin Lu, Zhe Ma, et al.
Frontiers in Oncology|November 17, 2022
Association of inflammatory markers with survival in patients with advanced gastric cancer treated with immune checkpoint inhibitors combined with chemotherapy as first line treatmentMingyu Wan, Yongfeng Ding, Chenyu Mao, et al.
Frontiers in Oncology|July 9, 2020
Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Combined Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Stage IV Advanced Gastric CancerHuan Wang, Yongfeng Ding, Ning Li, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
American Journal of Cancer Research|April 1, 2021
FSTL1 promotes growth and metastasis in gastric cancer by activating AKT related pathway and predicts poor survivalMengjie Wu, Yongfeng Ding, Nan Wu, et al.
Journal of Cancer|April 4, 2022
EXOSC5 promotes proliferation of gastric cancer through regulating AKT/STAT3 signaling pathwaysXiangliu Chen, Yingying Huang, Jin Liu, et al.
Heliyon|August 22, 2024
The combination of exon sequencing and metabolomics to establish a molecular typing system for gastric cancerShanshan Yu, Ming Chen, Xiaohua Zhu, et al.
Biomed Research International|July 18, 2019
Neoantigens Derived from Recurrently Mutated Genes as Potential Immunotherapy Targets for Gastric CancerJie Zhou, Wenyi Zhao, Jingcheng Wu, et al.
Frontiers in Immunology|February 26, 2021
Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to TherapyWeiqin Jiang, Yinjun He, Wenguang He, et al.
Journal of Translational Medicine|October 2, 2019
90-gene signature assay for tissue origin diagnosis of brain metastasesYulong Zheng, Yongfeng Ding, Qifeng Wang, et al.
Cancer Medicine|October 3, 2023
The Memorial Sloan Kettering Prognostic Score: Correlation with survival in patients with advanced gastric cancerMingyu Wan, Yongfeng Ding, Xiaolu Ma, et al.
Frontiers in Immunology|July 15, 2022
Development of a Humanized VHH Based Recombinant Antibody Targeting Claudin 18.2 Positive CancersWeixiang Zhong, Yimin Lu, Zhe Ma, et al.
Frontiers in Oncology|November 17, 2022
Association of inflammatory markers with survival in patients with advanced gastric cancer treated with immune checkpoint inhibitors combined with chemotherapy as first line treatmentMingyu Wan, Yongfeng Ding, Chenyu Mao, et al.
Frontiers in Oncology|July 9, 2020
Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Combined Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Stage IV Advanced Gastric CancerHuan Wang, Yongfeng Ding, Ning Li, et al.
Pageof 7